Suggestions
David Dehler
Executive Director Business Development at AIT Bioscience
Professional Background
David Dehler is a highly accomplished professional with an extensive career spanning over three decades in the preclinical contract research organization (CRO) sector. His vast experience has allowed him to develop a deep specialization in areas such as toxicology, ADME/PK (Absorption, Distribution, Metabolism, and Excretion / Pharmacokinetics), bioanalytical chemistry, and medicinal/process chemistry. Having worked for prestigious organizations like Hazleton Labs, Corning Labs, and Covance, David has built a notable career trajectory that displays his expertise and commitment to advancing the fields of biotech and pharma.
From 1985 until 2003, David honed his skills at various high-profile laboratories, including Hazleton Labs, where he served in multiple roles, ultimately working his way up to becoming a group leader. His hands-on experience included critical roles as a histotech and necropsy tech, where he directed his attention to important scientific analyses essential in toxicological studies. Notably, his time at Covance positioned him well for future roles, cementing his reputation as a reliable authority in the industry.
After leaving Covance, David joined Exygen Labs for a brief period before making significant contributions to Gene Logic Labs, which later became part of the Bridge organization. There, he managed teams focused on preclinical studies, further solidifying his credentials as a leader in toxicology and client services. His commitment to excellence led him to positions at Ricerca Biosciences, Eurofins Scientific, QPS, and Smithers Avanza. Notably, from September 2012 until September 2016, he served as the Executive Director of Sales & Marketing at Smithers Avanza, where he played a crucial role in shaping the organization’s business strategy and direction.
In his latest role, David holds a prominent position as the Executive Director of Business Development at AIT Bioscience. Here, he uses his extensive experience to foster growth and forge crucial partnerships essential for the development of preclinical services. David's ability to engage clients and develop bespoke solutions has been a driving force behind the success of the organizations he has worked with.
Education and Achievements
David Dehler has a robust educational background that has equipped him with the foundational knowledge necessary for his esteemed career in toxicology and related fields. He pursued studies in Toxicology at American University and obtained a Bachelor of Arts (B.A.) degree in Biology and Environmental Science from the State University of New York College at Purchase. His education focused on understanding the complexities of biological processes and their interrelations, providing him with sequential tools that have supported his professional journey.
Throughout his career, David has accumulated numerous accolades due to his expertise in business development and client relations. His specialties include client interaction, management, and the negotiation of contracts and agreements, showcasing his versatility in the industry. His proficiency in marketing and branding, especially within the biotech and pharmaceutical sectors, has significantly contributed to the growth initiatives of the organizations he has been part of. David also takes pride in mentoring and supporting the next generation of professionals in the field, highlighting his dedication to fostering growth not just in business endeavors but also in human capital.
Achievements
Some of David Dehler's notable achievements include:
- Strategic Business Development: As a business development leader, David has successfully initiated and managed partnerships that have led to increased revenue and enhanced service offerings across multiple organizations spanning the preclinical CRO landscape.
- Leadership and Management: Throughout his career, David has held various senior leadership roles, demonstrating exceptional capabilities in managing teams to achieve common goals while ensuring high-quality service and commitment to clients’ needs.
- Innovative Solutions: David's work in toxicology has significantly improved preclinical study designs, leading to effective methodologies in testing that benefit the wider scientific community.
- Market Expansion: Under David’s guidance, past organizations have expanded their market presence by leveraging modern marketing strategies and establishing strong brand recognition in competitive markets.
In summary, David Dehler’s expansive career has been marked by a persistent pursuit of excellence in the fields of toxicology, business development, and client services within preclinical CROs. His educational foundation and professional prowess make him a respected leader in the industry who continually strives for innovation and growth. His contributions enrich the biotech and pharmaceutical landscapes, reflecting his commitment to advancing both science and client satisfaction.